363 related articles for article (PubMed ID: 36140729)
1. Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ; Calvo X; Arenillas L
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140729
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Acquired Sideroblastic Anemias.
Mangaonkar AA; Patnaik MM
Hematol Oncol Clin North Am; 2020 Apr; 34(2):401-420. PubMed ID: 32089219
[TBL] [Abstract][Full Text] [Related]
3. Refractory anemia with ring sideroblasts.
Malcovati L; Cazzola M
Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in the knowledge of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2022; 63(6):600-607. PubMed ID: 35831194
[TBL] [Abstract][Full Text] [Related]
6. [Ring sideroblasts and iron metabolism].
Fujiwara T
Rinsho Ketsueki; 2020; 61(7):770-778. PubMed ID: 32759564
[TBL] [Abstract][Full Text] [Related]
7. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".
Patnaik MM; Tefferi A
Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial iron metabolism and sideroblastic anemia.
Sheftel AD; Richardson DR; Prchal J; Ponka P
Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
[TBL] [Abstract][Full Text] [Related]
10. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970
[TBL] [Abstract][Full Text] [Related]
11. [Biology of sideroblastic anemia].
Harigae H
Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management".
Patnaik MM; Tefferi A
Am J Hematol; 2021 Mar; 96(3):379-394. PubMed ID: 33428785
[TBL] [Abstract][Full Text] [Related]
13. [Molecular pathophysiology of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.
Malcovati L; Cazzola M
Br J Haematol; 2016 Sep; 174(6):847-58. PubMed ID: 27391606
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
Edahiro Y; Ochiai T; Hashimoto Y; Morishita S; Shirane S; Inano T; Furuya C; Koike M; Noguchi M; Usuki K; Shiratsuchi M; Nakajima K; Ohtsuka E; Tanaka H; Kawata E; Nakamae M; Ueda Y; Aota Y; Sugita Y; Ohara S; Yamasaki S; Asagoe K; Yoshida S; Yamanouchi J; Suzuki S; Kondo T; Kanisawa Y; Toyama K; Omura H; Mizuchi D; Sakamaki S; Ando M; Komatsu N
Int J Hematol; 2023 Jul; 118(1):47-53. PubMed ID: 37058247
[TBL] [Abstract][Full Text] [Related]
16. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess].
Meng FK; Huang LF; Zhou JF; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis with Cooccurrent SF3B1 and MPL Gene Mutations: A Case Report and Brief Review of the Literature.
Park CH; Yun JW; Kim HY; Lee KO; Kim SH; Kim HJ
Lab Med; 2020 May; 51(3):315-319. PubMed ID: 31858134
[TBL] [Abstract][Full Text] [Related]
18. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
19. Hereditary sideroblastic anemia: pathophysiology and gene mutations.
Harigae H; Furuyama K
Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
Mangaonkar AA; Lasho TL; Ketterling RP; Reichard KK; Gangat N; Al-Kali A; Begna KH; Pardanani A; Al Ali NH; Talati C; Sallman D; Padron E; Patnaik MM; Tefferi A; Komrokji R
Blood Cancer J; 2022 Feb; 12(2):26. PubMed ID: 35105856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]